Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 1072, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaplan, L. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kaplan, L. A.
Related Collections
Right arrow Drug Monitoring and Toxicology
Right arrow National Academy of Clinical Biochemistry
(Clinical Chemistry. 1998;44:1072.)
© 1998 American Association for Clinical Chemistry, Inc.

NACB Symposium

Standards of laboratory practice: guidelines for the maintaining of a modern therapeutic drug monitoring service

Lawrence A. Kaplan

Department of Pathology, New York University Medical Center, Bellevue Hospital, First Avenue & 27th Street, New York, NY 10016. Fax 212-263-8284; e-mail kaplan@is2.nyu.edu.


   Introduction
 
On Saturday, June 19, 1997 the National Academy of Clinical Biochemistry held a meeting to publicly review a draft document containing recommendations on the provision of basic therapeutic drug monitoring (TDM) services. This was the third in a continuing series of meetings on Standards of Laboratory Practice (SOLP), which was established to provide practice guidelines for laboratory scientists in a focused area of laboratory medicine. The manuscripts and summaries of two earlier SOLPs, on Thyroid Disease (1) and on Support of the Newborn (2), were published in this Journal, and the monographs are available from the NACB.

By facilitating discussion between clinical laboratory analysts . . . [Full Text of this Article]


   References
 



The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
J. M. Juenke, P. I. Brown, F. M. Urry, and G. A. McMillin
Specimen Dilution for C2 Monitoring with the Abbott TDxFLx Cyclosporine Monoclonal Whole Blood Assay
Clin. Chem., August 1, 2004; 50(8): 1430 - 1433.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.